Evonik says it is reorganizing two business lines to strengthen their growth prospects —Coating & Adhesive Resins and Health Care. The remaining businesses outside these cores will be sold to new owners or incorporated into partnerships.
The Coating & Adhesive Resins business line will focus on two core areas for growth: liquid polybutadienes as additives for adhesives and sealants or tires, and specialty acrylics for medical technology and the packaging industry. The business line’s existing polyolefins business, with sales of around €100 million, will be transferred to the C4 chain business at Evonik.
“Our industry is undergoing fundamental structural change worldwide,” said Christian Kullmann, chairman of the executive board of Evonik. “We will align all our resources with our strongest businesses. Only then can we seize growth opportunities in these markets at the necessary speed. Conversely, this also means that for businesses where we cannot offer appropriate prospects at Evonik, we will implement solutions outside Evonik.”